ArticleWorld journal of gastroenterology2009
Celiac disease in patients with presumed irritable bowel syndrome: a case-finding study.
Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.The American journal of gastroenterology · 2017Pooled it
- Gluten and Functional Abdominal Pain Disorders in Children.Nutrients · 2018Review
- Is celiac disease misdiagnosed in children with functional constipation?The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2018Article
- The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes.Przeglad gastroenterologiczny · 2016Article
- Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.World journal of gastroenterology · 2015Article
- Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study.Arthritis research & therapy · 2013Article
- The bowel and migraine: update on celiac disease and irritable bowel syndrome.Current pain and headache reports · 2012Review
- Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2012Article
- An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.Gastroenterology & hepatology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo estimate the prevalence of celiac disease (CD) in adult patients with presumed irritable bowel syndrome (IBS).
methodsBetween March 2005 and December 2008, 742 consecutive patients (293 male, median age 43 years, range 18-69 years) fulfilling the Rome II criteria for IBS were prospectively enrolled in the study. IBS was diagnosed via self-completed Rome II modular questionnaires. Anti-tissue transglutaminase (anti-tTG) serology was checked to initially recognize possible CD cases. Patients with a positive test were offered endoscopic duodenal biopsy to confirm the diagnosis of CD.
resultsThirty two patients (15 male, median age 41 years, range 19-59 years) were found to have organic diseases other than CD. Twenty four patients tested positive for anti-tTG antibodies, and duodenal biopsies confirmed the diagnosis in all of them. Thus, in this patient population with presumed IBS, 3.23% actually had CD.
conclusionCD is common in patients with presumed IBS. Routine screening for CD in patients with symptoms of IBS is recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.